Business
Oxford and AstraZeneca resume UK coronavirus vaccine trial – ABC News
Regulators give researchers the green light to continue a study that was suspended when a patient in the UK reportedly suffered a side-effect.
Oxford University has announced it will resume a trial for a coronavirus vaccine it is developing with pharmaceutical company AstraZeneca after getting the green light from safety watchdogs.
Key points:
- Globally some 18,000 people have received the trial vaccine
- The vaccine was in late-stage clinical trials in the US, Britain, Brazil and South Africa
- The US was aiming for fast-track approval of a vaccine before November’s presidential election
The late-stage …
Continue Reading
-
Noosa News23 hours agoState clears the way for farmland on Brisbane fringe to be developed
-
General18 hours agoPrada to buy rival Versace in $2.3 billion deal
-
General16 hours agoAustralian economy still vulnerable to US bond turmoil
-
General22 hours agoEU puts countermeasures on hold after US tariff pause